Fig. 3From: Manufacture and evaluation of a HER2-positive breast cancer immunotoxin 4D5Fv-PE25Purification process and freeze-dried products of 4D5Fv-PE25. A: Purifying processes of the 4D5Fv-PE25. B: Freeze-dried powder of the 4D5Fv-PE25.Back to article page